The term “Pediatric” CML does not only indicate the age of a patient affected from CML BCR-ABL1 but also points to distinct biological features (see below Section 9) which are observed with decreasing frequency from the 3rd to 6th decade of life. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.